Literature DB >> 10632242

A preliminary investigation of a protein kinase C inhibitor in the treatment of acute mania.

J M Bebchuk, C L Arfken, S Dolan-Manji, J Murphy, K Hasanat, H K Manji.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10632242     DOI： 10.1001/archpsyc.57.1.95

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN： 0003-990X


× No keyword cloud information.
  41 in total

Review 1.  Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects.

Authors:  Jorge A Quiroz; Rodrigo Machado-Vieira; Carlos A Zarate; Husseini K Manji
Journal:  Neuropsychobiology       Date:  2010-05-07       Impact factor: 2.328

Review 2.  New therapeutic targets for mood disorders.

Authors:  Rodrigo Machado-Vieira; Giacomo Salvadore; Nancy DiazGranados; Lobna Ibrahim; David Latov; Cristina Wheeler-Castillo; Jacqueline Baumann; Ioline D Henter; Carlos A Zarate
Journal:  ScientificWorldJournal       Date:  2010-04-13

3.  The underlying neurobiology of bipolar disorder.

Authors:  Husseini K Manji; Jorge A Quiroz; Jennifer L Payne; Jaskaran Singh; Barbara P Lopes; Jenilee S Viegas; Carlos A Zarate
Journal:  World Psychiatry       Date:  2003-10       Impact factor: 49.548

Review 4.  Adrenergic pharmacology and cognition: focus on the prefrontal cortex.

Authors:  Brian P Ramos; Amy F T Arnsten
Journal:  Pharmacol Ther       Date:  2006-12-28       Impact factor: 12.310

5.  Protein kinase C inhibition: a target for treatment of mania.

Authors:  Mina Hah; Joachim F Hallmayer
Journal:  Curr Psychiatry Rep       Date:  2008-06       Impact factor: 5.285

Review 6.  Review of pharmacological treatment in mood disorders and future directions for drug development.

Authors:  Xiaohua Li; Mark A Frye; Richard C Shelton
Journal:  Neuropsychopharmacology       Date:  2011-09-07       Impact factor: 7.853

Review 7.  A role for the PKC signaling system in the pathophysiology and treatment of mood disorders: involvement of a functional imbalance?

Authors:  Erika Abrial; Guillaume Lucas; Hélène Scarna; Nasser Haddjeri; Laura Lambás-Señas
Journal:  Mol Neurobiol       Date:  2011-10-05       Impact factor: 5.590

Review 8.  A review of the preclinical and clinical evidence for protein kinase C as a target for drug development for bipolar disorder.

Authors:  Nancy DiazGranados; Carlos A Zarate
Journal:  Curr Psychiatry Rep       Date:  2008-12       Impact factor: 5.285

9.  Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania.

Authors:  Steven T Szabo; Rodrigo Machado-Vieira; Peixiong Yuan; Yun Wang; Yanling Wei; Cynthia Falke; Chiara Cirelli; Giulio Tononi; Husseini K Manji; Jing Du
Journal:  Neuropharmacology       Date:  2008-08-22       Impact factor: 5.250

10.  Human disease-drug network based on genomic expression profiles.

Authors:  Guanghui Hu; Pankaj Agarwal
Journal:  PLoS One       Date:  2009-08-06       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.